3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
7
Other solid neoplasm
7
Gynecologic
2
Genitourinary
2
Sarcoma
1
Gastrointestinal
1
Breast
1
Conditions
Sarcoma
3
Osteosarcoma
2
Stomach Neoplasms
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Bone Neoplasms
1
Interventions
regorafenib
2
Doxorubicin
2
Cyclophosphamide
2
Cisplatin
2
tislelizumab
1
tazemetostat
1
sodium thiosulfate
1
entinostat
1
alanosine
1
X-Rays
1
Tamoxifen
1
Specimen Handling
1
Radiotherapy
1
Platinum
1
Magnetic Resonance Spectroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fentanyl
1
Etoposide
1
Erlotinib Hydrochloride
1
Cytoreduction Surgical Procedures
1
Clinical Trials, Phase II as Topic
1
Celecoxib
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Platinum
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled